Trademark Overview
On Tuesday, February 6, 2024, a trademark application was filed for XORBECY with the United States Patent and Trademark Office. The USPTO has given the XORBECY trademark a serial number of 98394866. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 10, 2024. This trademark is owned by Pfizer Inc.. The XORBECY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions